Company's DeepREAD AI model and small RNA expression system represent major leaps forward in RNA editing efficiency and specificity Generative AI model, trained on millions of experimental ...

Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates.